口腔鳞癌患者治疗前后免疫功能和肠道菌群变化的临床分析

doi:10.19439/j.sjos.2022.05.014

上海口腔医学 ›› 2022, Vol. 31 ›› Issue (5): 523-529.doi: 10.19439/j.sjos.2022.05.014

口腔鳞癌患者治疗前后免疫功能和肠道菌群变化的临床分析

钱毅^1,2, 邓超³, 许晓波⁴, 陈叶俊⁵, 胡媛平^1,2, 洪礼琳^1,2, 冯大军^1,2

1.安徽医科大学第一附属医院口腔科,安徽合肥 230012;
2.安徽省公共卫生临床中心,安徽合肥 230012;
3.皖南医学院口腔医学院,安徽芜湖 241002;
4.合肥市口腔医院特需诊疗中心,安徽合肥 230022;
5.安徽医科大学附属口腔医院,安徽合肥 230022

收稿日期:2022-03-18 修回日期:2022-04-28 出版日期:2022-10-25 发布日期:2022-11-01
通讯作者: 陈叶俊,E-mail: 493121512@qq.com
作者简介:钱毅(1978-),男,硕士,副主任医师,E-mail: jacqian@126.com
基金资助:
安徽医科大学校研基金项目（临床科学基金）（2021xkj180）

Clinical analysis of immune function, intestinal flora changes in patients with oral squamous carcinoma before, after treatment

QIAN Yi^1,2, DENG Chao³, XU Xiao-bo⁴, CHEN Ye-jun⁵, HU Yun-ping^1,2, HONG Li-lin^1,2, FENG Da-jun^1,2

1. Department of Stomatology, The First Affiliated Hospital of Anhui Medical University. Hefei 230012;
2. Anhui Public Health Clinical Center. Hefei 230012;
3. College of Dentistry, Wannan Medical College. Wuhu 241002;
4. Hefei Dental Hospital Special Needs Treatment Center. Hefei 230022;
5. Anhui Medical University Dental Hospital. Hefei 230022, Anhui Province, China

Received:2022-03-18 Revised:2022-04-28 Online:2022-10-25 Published:2022-11-01

摘要/Abstract

摘要： 目的: 研究口腔鳞状细胞癌（OSCC）患者常规治疗前后肠道菌群和免疫功能变化情况。方法: 选择2020年9月—2021年9月于安徽医科大学第一附属医院进行治疗的28例OSCC患者和10例健康志愿者为研究对象。OSCC患者经评估后给予治疗方案,记录患者治疗前1周和治疗6个月后临床症状、免疫功能和肠道菌群变化。采用GraphPad Prism 9.0软件包对数据进行统计学分析。结果: 免疫功能检测结果发现,与健康志愿者相比,OSCC患者治疗前外周血中淋巴细胞亚群（包括CD3⁺、CD4⁺、NK、CD4⁺/CD8⁺）和免疫球蛋白（包括IgG、IgA、IgM）水平明显偏低（P<0.05）,血清细胞因子（包括TNF-α、IL-4、IL-6）水平偏高（P<0.05）。经6个月治疗后,OSCC患者免疫功能相较于治疗前有所提高（P<0.05）,血清中促炎因子水平降低（P<0.05）。肠道菌群检测结果发现,与健康志愿者相比,OSCC患者治疗前肠道菌群多样性降低,治疗后,OSCC患者肠道菌群多样性有所恢复。菌群分布门水平上,与健康志愿者相比,OSCC患者治疗前肠道内Epsilonbacteraeota、Proteobacteria和Patescibacteria升高,Verrucomicrobia水平降低（P<0.05）。治疗降低了Epsilonbacteraeota、Proteobacteria和Patescibacteria水平,提高了Verrucomicrobia水平（P<0.05）。短链脂肪酸方面,与健康志愿者相比,OSCC患者治疗前肠道短链脂肪酸（包括乙酸、丙酸和丁酸）含量降低,治疗后,OSCC患者肠道短链脂肪酸含量升高。结论: 常规治疗后能明显提高OSCC患者免疫功能,恢复患者肠道菌群分布,提高肠道短链脂肪酸含量,改善患者健康水平。

关键词: OSCC, 免疫功能, 肠道菌群, 短链脂肪酸

Abstract: PURPOSE: To characterize the alterations of intestinal bacteria and immunological function in patients with oral squamous cell carcinoma(OSCC) before and after treatment. METHODS: From September 2020 to September 2021, 28 patients suffering OSCC and 10 healthy volunteers undergoing treatment at our hospital were enrolled in the study. Conventional treatment regimens were administered to OSCC patients and the changes in immune function, intestinal bacteria composition and short-chain fatty acids were measured 1 week before and 6 months after therapy. GraphPad Prism 9.0 software package was used for data analysis. RESULTS: Immunological function measurements indicated significantly lower levels of lymphocyte subsets (including CD3⁺, CD4⁺, NK, CD4⁺/CD8⁺) and immunoglobulins (including IgG, IgA, IgM) in the peripheral blood of OSCC patients before treatment compared to healthy volunteers (P<0.05), as well as remarkably lower levels of serum cytokines (including TNF-α、IL-4、IL-6) (P<0.05). Following 6 months of conventional treatment, there was an improvement in immune function in OSCC patients compared to all patients before treatment(P<0.05). Compared to healthy volunteers, the diversity of intestinal bacteria was decreased in OSCC patients before treatment, whereas the diversity of intestinal bacteria recovered in OSCC patients after conventional treatment. At the phylum, the distribution of Epsilonbacteraeota, Proteobacteria and Patescibacteria were significantly elevated and the concentration of Verrucomicrobia was decreased in OSCC patients before treatment compared to healthy volunteers(P<0.05). Intriguingly, convention therapy reversed the disturbance of intestinal bacteria, including downgrading levels of Epsilonbacteraeota, Proteobacteria and Patescibacteria and increasing levels of Verrucomicrobia(P<0.05). Short-chain fatty acids (including acetic acid, propionic acid and butyric acid) were present at a lower level in the intestine of OSCC patients before treatment and were elevated after conventional treatment. CONCLUSIONS: Conventional treatment remarkably enhances immune function, revitalizes the distribution of intestinal microflora, elevates the content of short-chain fatty acids in the intestine of OSCC patients, thereby improving the patients' health.

Key words: Oral squamous cell carcinoma, Immunological function, Intestinal bacteria, Short-chain fatty acids

中图分类号:

R781.4

钱毅, 邓超, 许晓波, 陈叶俊, 胡媛平, 洪礼琳, 冯大军. 口腔鳞癌患者治疗前后免疫功能和肠道菌群变化的临床分析[J]. 上海口腔医学, 2022, 31(5): 523-529.

QIAN Yi, DENG Chao, XU Xiao-bo, CHEN Ye-jun, HU Yun-ping, HONG Li-lin, FENG Da-jun. Clinical analysis of immune function, intestinal flora changes in patients with oral squamous carcinoma before, after treatment[J]. Shanghai Journal of Stomatology, 2022, 31(5): 523-529.

参考文献

[1] Nichols A, Theurer J, Prisman E, et al.Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR trial[J]. J Clin Oncol, 2022, 40(8): 866-875.
[2] Johnson D, Burtness B, Leemans C, et al.Head and neck squamous cell carcinoma[J]. Nat Rev Dis Primers, 2020, 6(1): 92-99.
[3] Hill S, D'andrea A. Predictive potential of head and neck squamous cell carcinoma organoids[J]. Cancer Discov, 2019, 9(7): 828-830.
[4] 陈晓华, 徐茂林. IL-10 多态性对牙周炎患者牙周微生态的影响[J]. 上海口腔医学, 2020, 29(5): 533-538.
[5] Park SY, Hwang BO, Lim M, et al.Oral-gut microbiome axis in gastrointestinal disease and cancer[J]. Cancers (Basel), 2021, 13(9): 2124.
[6] Turnbaugh PJ, Ley RE, Hamady M, et al.The human microbiome project[J]. Nature, 2007, 449(7164): 804-810.
[7] Krautkramer KA, Fan J, Bäckhed F.Gut microbial metabolites as multi-kingdom intermediates[J]. Nat Rev Microbiol, 2021, 19(2): 77-94.
[8] 中华口腔医学会口腔病理学专业委员会. 口腔癌及口咽癌病理诊断规范[J]. 中国口腔颌面外科杂志, 2020, 18(4): 289-296.
[9] Burstein HJ, Lacchetti C, Anderson H, et al.Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO Clinical Practice Guideline focused update[J]. J Clin Oncol, 2019, 37(5): 423-438.
[10] Huang Y, Yang B, Li W. Defining the normal core microbiome of conjunctival microbial communities[J]. Clin Microbiol Infect, 2016, 22(7): 643.e7-643.e12.
[11] Grajeda-Iglesias C, Durand S, Daillère R, et al.Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites[J]. Aging (Albany NY), 2021, 13(5): 6375-6405.
[12] Daisley BA, Chanyi RM, Abdur-Rashid K, et al.Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients[J]. Nat Commun, 2020, 11(1): 4822-4833.
[13] Al-Jaber A, Al-Nasser L, El-Metwally A.Epidemiology of oral cancer in Arab countries[J]. Saudi Med J, 2016, 37(3): 249-255.
[14] Tandon P, Dadhich A, Saluja H, et al.The prevalence of squamous cell carcinoma in different sites of oral cavity at our Rural Health Care Centre in Loni, Maharashtra - a retrospective 10-year study[J]. Contemp Oncol (Pozn), 2017, 21(2): 178-183.
[15] Muttagi SS, Chaturvedi P, Gaikwad R, et al.Head and neck squamous cell carcinoma in chronic areca nut chewing Indian women: Case series and review of literature[J]. Indian J Med Paediatr Oncol, 2012, 33(1): 32-35.
[16] Leemans C, Snijders P, Brakenhoff R.The molecular landscape of head and neck cancer[J]. Nat Rev Cancer, 2018, 18(5): 269-282.
[17] 靳能皓, 南欣荣, 闫星泉. BTG1在78 例口腔鳞癌中的表达及临床意义[J]. 上海口腔医学, 2021, 30(2): 140-144.
[18] Zheng D, Deng W, Song W, et al.Biomaterial-mediated modulation of oral microbiota synergizes with PD-1 blockade in mice with oral squamous cell carcinoma[J]. Nat Biomed Eng, 2022, 6(1): 32-43.
[19] Hayes R, Ahn J, Fan X, et al.Association of oral microbiome with risk for incident head and neck squamous cell cancer[J]. JAMA Oncol, 2018, 4(3): 358-365.
[20] Kenison J, Wang Z, Yang K, et al.The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation[J]. Proc Natl Acad Sci USA, 2021, 118(19): e2012692118.
[21] 吴毓聪, 程亚楠, 陈绍山, 等. IL-12 和 Th 亚群细胞在牙周病免疫病理及免疫调节中的作用[J]. 上海口腔医学, 2020, 29(5): 519-523.
[22] Liu D, Zhong M, Zhan D, et al.Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: focus on tumor immunity (Review)[J]. Oncol Rep, 2020, 44(6): 2337-2344.
[23] Garrido-Rodríguez V, Herrero-Fernández I, Castro MJ, et al.Immunological features beyond CD4/CD8 ratio values in older individuals[J]. Aging(Albany NY), 2021, 13(10): 13443-13459.
[24] Kumar S, Metz D, Ellenberg S, et al. Risk factors and incidence of gastric cancer after detection of helicobacter pylori infection: a large cohort study [J]. Gastroenterology, 2020, 158(3): 527-536.e7.
[25] Doorakkers E, Lagergren J, Engstrand L, et al.Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population[J]. Gut, 2018, 67(12): 2092-2096.
[26] Satheeshkumar P, Mohan M.Oral Helicobacter pylori infection and the risk of oral cancer[J]. Oral Oncol, 2013, 49(6): e20-e21.
[27] Meng X, Wang Q, He C, et al.An inverse association of Helicobacter pylori infection with oral squamous cell carcinoma[J]. J Oral Pathol Med, 2016, 45(1): 17-22.
[28] Cani P, Knauf C.A newly identified protein from Akkermansia muciniphila stimulates GLP-1 secretion[J]. Cell Metab, 2021, 33(6): 1073-1075.
[29] Derosa L, Routy B, Thomas AM, et al.Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer[J]. Nat Med, 2022, 28(2): 315-324.
[30] Blacher E, Bashiardes S, Shapiro H, et al.Potential roles of gut microbiome and metabolites in modulating ALS in mice[J]. Nature, 2019, 572(7770): 474-480.
[31] Derrien M, Belzer C, De Vos WM.Akkermansia muciniphila and its role in regulating host functions[J]. Microb. Pathog, 2017, 106: 171-181.
[32] Koh A, De Vadder F, Kovatcheva-Datchary P, et al.From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites[J]. Cell, 2016, 165(6): 1332-1345.
[33] 薛佳艺, 朱晓燕, 危常磊, 等. 25 例口腔鳞癌患者唾液代谢组学分析[J]. 上海口腔医学, 2021, 30(2): 201-205.
[34] Carley A, Maurya S, Fasano M, et al.Short-chain fatty acids outpace ketone oxidation in the failing heart[J]. Circulation, 2021, 143(18): 1797-1808.
[35] Bachem A, Makhlouf C, Binger K, et al. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8 T cells [J]. Immunity, 2019, 51(2): 285-297.e5.
[36] Zheng DW, Li RQ, An JX, et al.Prebiotics-encapsulated probiotic spores regulate gut microbiota and suppress colon cancer[J]. Adv Mater, 2020, 32(45): e2004529.

口腔鳞癌患者治疗前后免疫功能和肠道菌群变化的临床分析

Clinical analysis of immune function, intestinal flora changes in patients with oral squamous carcinoma before, after treatment

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

本文评价

[1]	李杨, 赵梦珺, 卢红巧, 刘建国, 刘云坤, 吴家媛. 基于16S rDNA高通量测序技术的重度低龄儿童龋患者口腔微生物及肠道菌群群落分析[J]. 上海口腔医学, 2024, 33(2): 164-169.
[2]	霍圆圆, 潘永海, 徐薇, 孙燕佩, 刘敏, 张华, 李宁毅. 动态营养支持对口腔颌面肿瘤术后能量代谢、免疫功能及应激反应的影响[J]. 上海口腔医学, 2020, 29(1): 89-92.
[3]	石磊, 陶峰, 刘瑞敏, 刘巧蓉. 高危TP53突变与口腔鳞状细胞癌中淋巴结外侵犯的相关性分析[J]. 上海口腔医学, 2019, 28(6): 644-647.
[4]	蓝余炼, 唐亮, 崔日林. 铁代谢在复发性口腔溃疡患者中的变化及其与细胞免疫功能的关系[J]. 上海口腔医学, 2017, 26(3): 302-304.